FOLH1 and neoplasm: Previously, we found that [177Lu]lutetium sesquioxide nanoparticles functionalized with FAP and PSMA inhibitor ligands (iFAP and iPSMA) ([177Lu]Lu−iFAP/iPSMA) prevent HCT116 tumor progression in mice [27].